JO
IBBQ icon

John Overdeck’s Invesco NASDAQ Biotechnology ETF IBBQ Stock Holding History

John Overdeck’s Portfolio IBBQ Stock Details IBBQ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.68M Hold
51,400
– – ﹤0.01% 3158
2026
Q1 		$1.49M Buy
51,400
+22,400
+77% +$652K ﹤0.01% 2982
2025
Q4 		$823K Buy
+29,000
New +$789K ﹤0.01% 3062

Other funds holding IBBQ

Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
WG
WMS Group Folsom, Louisiana $77.5M AUM
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
IAA
Independent Advisor Alliance Charlotte, North Carolina $4.27B AUM 45.92% 1-Year Est. Return
KAM
Knightsbridge Asset Management Newport Beach, California $762M AUM 59.13% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $8.83B AUM 38.5% 1-Year Est. Return
CFA
Churchill Financial Advisors Louisville, Kentucky $519M AUM
BCI
Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return
CA
Clearstead Advisors Cleveland, Ohio $10.6B AUM 24.87% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

John Overdeck's IBBQ Position: Q2 2026 in Review

John Overdeck held its Invesco NASDAQ Biotechnology ETF (IBBQ) position steady in Q2 2026 at 51,400 shares worth $1.68M. The position accounts for ﹤0.01% of the portfolio, ranked #3158.

John Overdeck first reported a position in IBBQ in Q4 2025 and has held it in 3 quarters since. 35 funds tracked by Wall St. Rank hold IBBQ as of Q2 2026.

  • John Overdeck held 51,400 shares of Invesco NASDAQ Biotechnology ETF worth $1.68M as of Q2 2026.
  • John Overdeck left its Invesco NASDAQ Biotechnology ETF share count unchanged in Q2 2026.
  • Invesco NASDAQ Biotechnology ETF made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #3158 holding.
  • John Overdeck first reported a position in Invesco NASDAQ Biotechnology ETF in Q4 2025 and has held it in 3 quarters since.
  • 35 funds tracked by Wall St. Rank held Invesco NASDAQ Biotechnology ETF as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.